We've detected an Ad Blocker in your browser.
Please disable or pause the Ad Blocker and refresh the page to be able to register and access the website normally.
14–15 October 2022
3 daily broadcasts:
Bangkok - 14:20 ICT | Paris - 14:20 CEST | Rio - 14:20 BRT
REGISTER FREE
Watch Now On-demand
LOG IN
A TMA initiative in partnership with Radcliffe Cardiology
MTE & Satellite Symposium Sessions
(Please note this programme is subject to change)
Day 1 – Friday, October 14
- 16:10–16:50 ICT (Bangkok – UTC +7) – Meet the expert
Emerging evidence across the spectrum of heart failure: new insights from the deliver trial
John McMurray and Rudolf A. de Boer
Supported by an educational grant from AstraZeneca - 18:10–18:40 ICT (Bangkok – UTC +7) – Meet the expert
SGLT2 inhibition in patients with HFpEF ‒ a case-based discussion
Giuseppe Rosano and Anja Sandek
Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance. - 14:20–14:50 CEST (Paris – UTC +2) – Meet the expert
Improving exercise capacity and quality of life in patients with heart failure – the role of intravenous iron therapy
Mahir Karakas and Andrew Sindone
Supported by an unrestricted educational grant from CSL Vifor. - 16:10–16:50 CEST (Paris – UTC +2) – Satellite symposium
SGLT2 inhibition as foundational heart failure therapy: have we changed our practices?
Chairs: Andrews Coats and Shelley Zieroth
- SGLT2 inhibitors as heart failure drugs ‒ clinical trial evidence across the spectrum of ejection fraction: Stefan Anker
- SGLT2 inhibition in patients with heart failure ‒ practical: Daniela Tomasoni
- Optimizing foundational therapies in heart failure ‒ can we do better: Clara Saldarriaga
- Panel discussion
- 18:10–18:40 CEST (Paris – UTC +2) – Meet the expert
Best practice recommendations for the management of hyperkalemia
Clara Bonanad Lozano and Aaron Wong
Supported by an educational grant from AstraZeneca - 14:20–14:50 BRT (Rio – UTC -3) – Meet the expert
Hyperkalaemia in patients with heart failure – dreadful side effect or manageable condition?
Javed Butler and Ileana Piña
Supported by an unrestricted educational grant from CSL Vifor - 16:10–16:50 BRT (Rio – UTC -3) – Meet the expert
Sex differences in advanced heart failure
Andrew Coats and Aditi Nayak
Day 2 – Saturday, October 15
- 16:10–16:50 ICT (Bangkok – UTC +7) – Meet the expert
Unlocking the potential of baroreflex activation therapy (BAT) for HFrEF patients
Stefan Anker and Marat Fudim
Sponsored by an unrestricted grant from CVRx - 16:10–16:50 CEST (Paris – UTC +2) – Satellite symposium
Bridging the implementation gap in heart failure across the EF spectrum
Chair: Biykem Bozkurt
- Recent advances in the heart failure patient journey and management - Rosano Giuseppe
- Implementation of evidence-based heart failure treatments - Stephen Greene
- 14:20–14:50 BRT (Rio – UTC -3) – Meet the expert
SGLT2 inhibition in patients with HFrEF ‒ a case-based discussion
Ewa Jankowska and Daniela Tomasoni
Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance. - 16:10–16:50 BRT (Rio – UTC -3) – Meet the expert
Management of tricuspid regurgitation in heart failure
Stefan Anker and Philipp Lurz
Supported by an unrestricted educational grant from Edwards Lifesciences.
Sponsors:
If you’re interested in becoming an educational partner or sponsor at this event, please contact sales@radcliffe-group.com